HH
Howard Horn (Chief Financial Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Ultragenyx Pharmaceutical Inc. (RARE). The largest single filing was $156K of RARE (4,698 sh × $33.13, as filed), executed Jul 1. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$840K
shares × price, as filed
Last traded
Oct 15
Filed Oct 19
Median ADV $57.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
7 filings
Sector per market data · by filing · past 12 months
Most traded names
RARERecent filings
RARESALE
Ultragenyx Pharmaceutical Inc.
View filing →
$108K7,066 sh × $15.27
Exec Oct 15
Filed Oct 19 · 1:48 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $117K
4,696 sh × $24.92
Exec Aug 3
Filed Aug 4 · 3:13 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $156K
4,698 sh × $33.13
Exec Jul 1
Filed Jul 6 · 3:37 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $111K
4,653 sh × $23.77
Exec Jun 1
Filed Jun 1 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $117K
4,683 sh × $24.90
Exec May 1
Filed May 4 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $121K
5,290 sh × $22.80
Exec Mar 2
Filed Mar 3 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $112K
3,081 sh × $36.38
Exec Dec 10 2025
Filed Dec 11 2025 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $250K
7,942 sh × $31.51
Exec Oct 13 2025
Filed Oct 14 2025 · 5:30 PM ET